Detalhe da pesquisa
1.
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial.
Lancet
; 401(10371): 131-139, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495882
2.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
3.
The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.
Hum Resour Health
; 21(1): 88, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957695
4.
Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.
BMC Health Serv Res
; 23(1): 1033, 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759205
5.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet
; 397(10269): 99-111, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306989
6.
Seroepidemiology of respiratory syncytial virus infection in rural and semi-rural areas of the Littoral region of Cameroon.
BMC Infect Dis
; 21(1): 144, 2021 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33541281
7.
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Lancet
; 388(10040): 158-69, 2016 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27212429
8.
Landscaping analysis of immunization progress and program structures in selected middle income Southeast Asian countries.
Vaccine
; 42(9): 2326-2336, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448324
9.
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency.
Pathogens
; 13(4)2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668228
10.
The need and challenges for development of vaccines against emerging infectious diseases.
J Pediatr (Rio J)
; 99 Suppl 1: S37-S45, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495947
11.
SARS-CoV-2 and Dengue Coinfection in Filipino Children: Epidemiology Profile, Clinical Presentation and Outcomes.
Pediatr Infect Dis J
; 42(9): 787-791, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314214
12.
Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: A cross-sectional serological study.
Vaccine
; 41(39): 5769-5774, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573201
13.
The Hidden Impact of the COVID-19 Pandemic on Routine Childhood Immunization Coverage in Cameroon.
Vaccines (Basel)
; 11(3)2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992229
14.
Variation in reported neonatal group B streptococcal disease incidence in developing countries.
Clin Infect Dis
; 55(1): 91-102, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22523262
15.
Safety of the Fiocruz ChAdOx COVID-19 vaccine used in a mass vaccination campaign in Botucatu, Brazil.
Vaccine
; 40(47): 6722-6729, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055876
16.
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Lancet Infect Dis
; 22(7): 990-1001, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447085
17.
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia report.
Ann N Y Acad Sci
; 1518(1): 209-225, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183296
18.
Evaluation of the partnership between international non-governmental organizations and the State in the health sector in Mozambique.
Pan Afr Med J
; 39: 91, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34466193
19.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Nat Commun
; 12(1): 5861, 2021 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615860
20.
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
bioRxiv
; 2021 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981049